documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
106 rows where docket_id = "FDA-2015-N-0101" and posted_year = 2017 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
- Supporting & Related Material 88
- Other 17
- Rule 1
posted_year 1
- 2017 · 106 ✖
agency_id 1
- FDA 106
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2015-N-0101-1384 | FDA | None FDA-2015-N-0101 | 033 Reference 22 - International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, Guideline for Industry. The need for Carcinogenicity Studies re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:06:57Z | 0 | 0 | 0900006482cea5a1 | |||
| FDA-2015-N-0101-1388 | FDA | None FDA-2015-N-0101 | 037 Reference 26 - Guidance for Industry, M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:09:27Z | 0 | 0 | 0900006482cea5a5 | |||
| FDA-2015-N-0101-1376 | FDA | None FDA-2015-N-0101 | 025 Reference 14 - FDA_Letter_regarding_Deferral_of_Isopropyl_Alcohol re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:59:34Z | 0 | 0 | 0900006482cea90f | |||
| FDA-2015-N-0101-1377 | FDA | None FDA-2015-N-0101 | 026 Reference 15 - FDA_Letter_regarding_Deferral_of_Povidone_Iodine re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:00:28Z | 0 | 0 | 0900006482cea910 | |||
| FDA-2015-N-0101-1378 | FDA | None FDA-2015-N-0101 | 027 Reference 16 - Wheelock and Lookinland, Effect of surgical hand scrub time on subsequent bacterial growth re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:01:26Z | 0 | 0 | 0900006482cea911 | |||
| FDA-2015-N-0101-1399 | FDA | None FDA-2015-N-0101 | 048 Reference 37 - Sivaji et al 1986 Disinfectant Induced Changes in the Antibiotic Sensitivity and Phage Typing Pattern in S aureus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:17:42Z | 0 | 0 | 0900006482cea5b0 | |||
| FDA-2015-N-0101-1402 | FDA | None FDA-2015-N-0101 | 051 Reference 40 - Kunisada et al, Investigation on the efficacy of povidone-iodine against antiseptic-resistant species re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:19:37Z | 0 | 0 | 0900006482cea5b3 | |||
| FDA-2015-N-0101-1412 | FDA | None FDA-2015-N-0101 | 063 Reference 52 - Kawamura-Sato et al, Correlation between Reduced Susceptibility to Disinfectants and Multidrug Resistance among Clinical Isolates of Acinetobacter Species re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:27:44Z | 0 | 0 | 0900006482cea7c9 | |||
| FDA-2015-N-0101-1417 | FDA | None FDA-2015-N-0101 | 068 Reference 57 - Wiegand et al, Analysis of the Adaptation Capacity of Staphylococcus Aureus to Commonly Used Antiseptics by Microplate Laser Nephelometry re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:31:48Z | 0 | 0 | 0900006482cea7ce | |||
| FDA-2015-N-0101-1369 | FDA | None FDA-2015-N-0101 | 018 Reference 7 - CDC, Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:52:56Z | 0 | 0 | 0900006482cea908 | |||
| FDA-2015-N-0101-1375 | FDA | None FDA-2015-N-0101 | 024 Reference 13 - FDA_Letter_regarding_Deferral_of_Ethyl_Alcohol re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:58:37Z | 0 | 0 | 0900006482cea90e | |||
| FDA-2015-N-0101-1386 | FDA | None FDA-2015-N-0101 | 035 Reference 24 - FDA, Redbook 2000 IV.C.9.a Reproduction and Developmental Toxicity Studies Guidelines for Reproduction Studies re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:08:17Z | 0 | 0 | 0900006482cea5a3 | |||
| FDA-2015-N-0101-1364 | FDA | None FDA-2015-N-0101 | 013 Reference 2 -12 - Volume_IX_9_of_9_Published_Cited_References_Part_2_of_2_re_C12 re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:48:33Z | 0 | 0 | 0900006482cea4c0 | |||
| FDA-2015-N-0101-1382 | FDA | None FDA-2015-N-0101 | 031 Reference 20 - Phenolphthalein Exposure Causes Multiple Carcinogenic Effects in Experimental Model Systems re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:05:34Z | 0 | 0 | 0900006482cea915 | |||
| FDA-2015-N-0101-1408 | FDA | None FDA-2015-N-0101 | 059 Reference 48 - Weber et al, Use of germicides in the home and the healthcare setting re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:24:53Z | 0 | 0 | 0900006482cea5ba | |||
| FDA-2015-N-0101-1371 | FDA | None FDA-2015-N-0101 | 020 Reference 9 - Innovations in Health Care- Antisepsis as a Case Study re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:55:17Z | 0 | 0 | 0900006482cea90a | |||
| FDA-2015-N-0101-1351 | FDA | None FDA-2015-N-0101 | Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Rule | Final Rule | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T05:00:00Z | 2017-12-20T14:10:12Z | 2017-27317 | 0 | 0 | 0900006482d3e4e3 | |
| FDA-2015-N-0101-1355 | FDA | None FDA-2015-N-0101 | 003 Reference 2 -2 - Volume_II_2_of_9_Feedback_Meeting_and_Working_Texts_From_the_Feedback_Meeting_March_29_1995_Attachment_1_through_6_re_Comment_from_Soap_Deter re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:40:41Z | 0 | 0 | 0900006482ce9f70 | |||
| FDA-2015-N-0101-1359 | FDA | None FDA-2015-N-0101 | 007 Reference 2 -6 - Volume_V_5_of_9_References_Continuation_re_Comment_from_Soap_Detergent_Association_(SDA) re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:43:42Z | 0 | 0 | 0900006482cea4ba | |||
| FDA-2015-N-0101-1362 | FDA | None FDA-2015-N-0101 | 010 Reference 2 -9 - Volume_VII_7_of_9_References_Continuation_re_C12 re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:46:40Z | 0 | 0 | 0900006482cea4bd | |||
| FDA-2015-N-0101-1391 | FDA | None FDA-2015-N-0101 | 040 Reference 29 - Novel Water-Based Antiseptic Lotion Demonstrates Rapid, Broad-Spectrum Kill Compared with Alcohol Antiseptic re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:11:44Z | 0 | 0 | 0900006482cea5a8 | |||
| FDA-2015-N-0101-1395 | FDA | None FDA-2015-N-0101 | 044 Reference 33 - Bactericidal Activity of Antiseptics against Methicillin-Resistant Staphylococcus Aureus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:14:42Z | 0 | 0 | 0900006482cea5ac | |||
| FDA-2015-N-0101-1398 | FDA | None FDA-2015-N-0101 | 047 Reference 36 - Sivaji and Mandal 1987 Antibiotic Resistance and Serotypic Variations in E coli Induced by Disinfectants re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:17:10Z | 0 | 0 | 0900006482cea5af | |||
| FDA-2015-N-0101-1406 | FDA | None FDA-2015-N-0101 | 056 Reference 45 - Ghasemzadeh-Moghaddam et al, Methicillin-Susceptible and -Resistant Staphylococcus Aureus with High-Level Antiseptic re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:22:32Z | 0 | 0 | 0900006482cea5b7 | |||
| FDA-2015-N-0101-1372 | FDA | None FDA-2015-N-0101 | 021 Reference 10 - FDA_Letter_regarding_Deferral_of_Benzalkonium_Chloride re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:56:00Z | 0 | 0 | 0900006482cea90b | |||
| FDA-2015-N-0101-1422 | FDA | None FDA-2015-N-0101 | 073 Reference 62 - Barry et al, Lack of Effect of Antibiotic Resistance on Susceptibility of Microorganisms to Chlorhexidine Gluconate or Povidone Iodine re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:37:21Z | 0 | 0 | 0900006482ceabe2 | |||
| FDA-2015-N-0101-1434 | FDA | None FDA-2015-N-0101 | 085 Reference 74 - Copitch et al, Prevalence of decreased susceptibility to triclosan in Salmonella enterica isolates from animals and humans and association with multiple re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:42:47Z | 0 | 0 | 0900006482ceabee | |||
| FDA-2015-N-0101-1437 | FDA | None FDA-2015-N-0101 | 088 Reference 77 - Joynson et al, Adaptive Resistance to Benzalkonium Chloride, Amikacin and Tobramycin re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:44:09Z | 0 | 0 | 0900006482ceabf1 | |||
| FDA-2015-N-0101-1390 | FDA | None FDA-2015-N-0101 | 039 Reference 28 - Comparative in vitro activities of topical wound care products against community-associated methicillin-resistant Staphylococcus aureus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:10:56Z | 0 | 0 | 0900006482cea5a7 | |||
| FDA-2015-N-0101-1400 | FDA | None FDA-2015-N-0101 | 049 Reference 38 - Comparative in vitro efficacy of antimicrobial re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:18:18Z | 0 | 0 | 0900006482cea5b1 | |||
| FDA-2015-N-0101-1367 | FDA | None FDA-2015-N-0101 | 016 Reference 5 - Part 130 New Drugs-Procedures for Classification of Over-the-Counter Drugs re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:51:15Z | 0 | 0 | 0900006482cea906 | |||
| FDA-2015-N-0101-1368 | FDA | None FDA-2015-N-0101 | 017 Reference 6 - Tuuli et al, A randomized trial comparing skin antiseptic agents at cesarean delivery re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:51:57Z | 0 | 0 | 0900006482cea907 | |||
| FDA-2015-N-0101-1370 | FDA | None FDA-2015-N-0101 | 019 Reference 8 - Mangram et al, Guideline for prevention of surgical site infection re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:53:43Z | 0 | 0 | 0900006482cea909 | |||
| FDA-2015-N-0101-1353 | FDA | None FDA-2015-N-0101 | 001 Reference 1 - Transcript of the January 22, 1997, Meeting of the Joint Nonprescription Drugs and Anti-Infective Drugs Advisory Committees re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:39:14Z | 0 | 0 | 0900006482ce9f6e | |||
| FDA-2015-N-0101-1360 | FDA | None FDA-2015-N-0101 | 008 Reference 2 -7 - Volume_V_5_of_9_Published_Cited_References_Part_2_of_2_re_Comment_from_Soap_Detergent_Association_(SDA) re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:45:27Z | 0 | 0 | 0900006482cea4bb | |||
| FDA-2015-N-0101-1387 | FDA | None FDA-2015-N-0101 | 036 Reference 25 - USEPA, Guidelines for Reproductive Toxicity Risk Assessment re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:08:53Z | 0 | 0 | 0900006482cea5a4 | |||
| FDA-2015-N-0101-1421 | FDA | None FDA-2015-N-0101 | 072 Reference 61 - Gorden and Mclure, In-vitro comparison of bactericidal activity of povidone iodine and re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:36:19Z | 0 | 0 | 0900006482ceabe1 | |||
| FDA-2015-N-0101-1428 | FDA | None FDA-2015-N-0101 | 079 Reference 68 - Coelho et al, The Use of Machine Learning Methodologies to Analyse Antibiotic and Biocide Susceptibility in Staphylococcus Aureus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:41:52Z | 0 | 0 | 0900006482ceabe8 | |||
| FDA-2015-N-0101-1392 | FDA | None FDA-2015-N-0101 | 041 Reference 30 - Absence of role for plasmids in resistance to multiple disinfectants in three stains re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:12:26Z | 0 | 0 | 0900006482cea5a9 | |||
| FDA-2015-N-0101-1409 | FDA | None FDA-2015-N-0101 | 060 Reference 49 - Rajamohan et al, Biocide-Tolerant Multidrug-Resistant Acinetobacter Baumannii Clinical Strains Are Associated with re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:25:34Z | 0 | 0 | 0900006482cea5bb | |||
| FDA-2015-N-0101-1415 | FDA | None FDA-2015-N-0101 | 066 Reference 55 - Lanker Klossner et al, Nondevelopment of resistance by bacteria during hospital use of povidone-iodine re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:30:41Z | 0 | 0 | 0900006482cea7cc | |||
| FDA-2015-N-0101-1365 | FDA | None FDA-2015-N-0101 | 014 Reference 3 - Transcript of the March 23, 2005, Nonprescription Drugs Advisory Committee re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:49:43Z | 0 | 0 | 0900006482cea904 | |||
| FDA-2015-N-0101-1366 | FDA | None FDA-2015-N-0101 | 015 Reference 4 - Transcript of the September 3, 2014, Meeting of the Nonprescription Drugs Advisory Committee 2014 re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:50:24Z | 0 | 0 | 0900006482cea905 | |||
| FDA-2015-N-0101-1424 | FDA | None FDA-2015-N-0101 | 075 Reference 64 - Sakuragi et al, Bactericidal activity of skin disinfectants on methicillin-resistant Staphylococcus aureus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:39:10Z | 0 | 0 | 0900006482ceabe4 | |||
| FDA-2015-N-0101-1426 | FDA | None FDA-2015-N-0101 | 077 Reference 66 - Payne et al, Antiseptics-A forgotten weapon in the control of antibiotic resistant bacteria in hospital and re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:40:30Z | 0 | 0 | 0900006482ceabe6 | |||
| FDA-2015-N-0101-1397 | FDA | None FDA-2015-N-0101 | 046 Reference 35 - Resistance Mechanisms of Mucoid-Grown Staphylococcus Aureus to the Antibacterial Action of Some Disinfectants and Antiseptics re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:16:10Z | 0 | 0 | 0900006482cea5ae | |||
| FDA-2015-N-0101-1403 | FDA | None FDA-2015-N-0101 | 052 Reference 41 - Lacey et al, Antiseptic resistance in methicillin-resistant Staphylococcus aureus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:20:22Z | 0 | 0 | 0900006482cea5b4 | |||
| FDA-2015-N-0101-1404 | FDA | None FDA-2015-N-0101 | 053 Reference 42 - Sensitivities to Biocides and Distribution of Biocide Resistance Genes in Quaternary Ammonium Compound re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:21:02Z | 0 | 0 | 0900006482cea5b5 | |||
| FDA-2015-N-0101-1439 | FDA | None FDA-2015-N-0101 | 057 Reference 46 - Noguchi et al, Susceptibilities to antiseptic agents and distribution of antiseptic-resistance genes qacAB and smr of methicillin-resistant Staphylococcus aureus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:44:57Z | 0 | 0 | 0900006482cea5b8 | |||
| FDA-2015-N-0101-1416 | FDA | None FDA-2015-N-0101 | 067 Reference 56 - Prince et al, Drug Resistance Studies with Topical Antiseptics re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:31:14Z | 0 | 0 | 0900006482cea7cd | |||
| FDA-2015-N-0101-1352 | FDA | None FDA-2015-N-0101 | Reference List re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:39:02Z | 0 | 0 | 0900006482ce9f6c | |||
| FDA-2015-N-0101-1420 | FDA | None FDA-2015-N-0101 | 071 Reference 60 - Yasuda et al 1993 Comparison of Bactericidal Activities of Various Disinfectants Against MSSA and MRSA re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:33:42Z | 0 | 0 | 0900006482ceabe0 | |||
| FDA-2015-N-0101-1431 | FDA | None FDA-2015-N-0101 | 082 Reference 71 - Shi et al, Prevalence of Antiseptic-Resistance Genes in Staphylococci Isolated from Orthokeratology Lens and Spectacle re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:42:18Z | 0 | 0 | 0900006482ceabeb | |||
| FDA-2015-N-0101-1410 | FDA | None FDA-2015-N-0101 | 061 Reference 50 - Akinkunmi et al, Susceptibility of Community Associated Methicillin Resistant Staphylococcus Aureus Isolated re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:26:11Z | 0 | 0 | 0900006482cea5bc | |||
| FDA-2015-N-0101-1411 | FDA | None FDA-2015-N-0101 | 062 Reference 51 - Kawamura-Sato et al, Reduction of Disinfectant Bactericidal Activities in Clinically Isolated Acinetobacter Species re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:27:02Z | 0 | 0 | 0900006482cea7c8 | |||
| FDA-2015-N-0101-1358 | FDA | None FDA-2015-N-0101 | 006 Reference 2 -5 - Volume_IV_4_of_9_Published_Cited_References_Part_2_of_2_re_Comment_from_Soap_Detergent_Association_(SDA) re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:42:55Z | 0 | 0 | 0900006482ce9f73 | |||
| FDA-2015-N-0101-1381 | FDA | None FDA-2015-N-0101 | 030 Reference 19 - Summary Minutes of the September 3, 2014 Nonprescription Drugs Advisory Committee Meeting re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:04:42Z | 0 | 0 | 0900006482cea914 | |||
| FDA-2015-N-0101-1423 | FDA | None FDA-2015-N-0101 | 074 Reference 63 - Rikimaru et al, Efficacy of Common Antiseptics against Multidrug-Resistant Mycobacterium Tuberculosis re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:38:33Z | 0 | 0 | 0900006482ceabe3 | |||
| FDA-2015-N-0101-1427 | FDA | None FDA-2015-N-0101 | 078 Reference 67 - Oggioni et al, Significant Differences Characterise the Correlation Coefficients between Biocide and Antibiotic re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:41:13Z | 0 | 0 | 0900006482ceabe7 | |||
| FDA-2015-N-0101-1430 | FDA | None FDA-2015-N-0101 | 081 Reference 70 - Buffet-Bataillon et al, Effect of higher minimum inhibitory concentrations of quaternary ammonium compounds in clinical E. coli isolates on antibiotic re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:42:07Z | 0 | 0 | 0900006482ceabea | |||
| FDA-2015-N-0101-1432 | FDA | None FDA-2015-N-0101 | 083 Reference 72 - Lambert, Comparative Analysis of Antibiotic and Antimicrobial Biocide Susceptibility Data in Clinical Isolates of Methicillin-Sensitive Staphylococcus Aureus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:42:30Z | 0 | 0 | 0900006482ceabec | |||
| FDA-2015-N-0101-1433 | FDA | None FDA-2015-N-0101 | 084 Reference 73 - Morrissey et al, Evaluation of Epidemiological Cut-Off Values Indicates that Biocide Resistant Subpopulations Are Uncommon in Natural Isolates of Clinically re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:42:39Z | 0 | 0 | 0900006482ceabed | |||
| FDA-2015-N-0101-1438 | FDA | None FDA-2015-N-0101 | 089 Reference 78 - FDA Regulatory Impact Analysis, Safety and Effectiveness for Health Care Antiseptics re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:44:18Z | 0 | 0 | 0900006482ceabf2 | |||
| FDA-2015-N-0101-1414 | FDA | None FDA-2015-N-0101 | 065 Reference 54 - Rikimaru et al, Bactericidal Activities of Commonly Used Antiseptics against Multidrug-Resistant re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:30:01Z | 0 | 0 | 0900006482cea7cb | |||
| FDA-2015-N-0101-1374 | FDA | None FDA-2015-N-0101 | 023 Reference 12 - FDA_Letter_regarding_Deferral_of_Chloroxylenol re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:57:59Z | 0 | 0 | 0900006482cea90d | |||
| FDA-2015-N-0101-1425 | FDA | None FDA-2015-N-0101 | 076 Reference 65 - Sanchez et al, The Biocide Triclosan Selects Stenotrophomonas Maltophilia Mutants That Overproduce the Smedef re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:39:48Z | 0 | 0 | 0900006482ceabe5 | |||
| FDA-2015-N-0101-1436 | FDA | None FDA-2015-N-0101 | 087 Reference 76 - Langsrud et al, Cross-Resistance to Antibiotics of Escherichia Coli Adapted to Benzalkonium Chloride or re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:43:57Z | 0 | 0 | 0900006482ceabf0 | |||
| FDA-2015-N-0101-1389 | FDA | None FDA-2015-N-0101 | 038 Reference 27 - Guidance for Industry, Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:10:10Z | 0 | 0 | 0900006482cea5a6 | |||
| FDA-2015-N-0101-1394 | FDA | None FDA-2015-N-0101 | 043 Reference 32 - Bactericidal Activities of Disinfectants against Vancomycin-Resistant Enterococci re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:14:05Z | 0 | 0 | 0900006482cea5ab | |||
| FDA-2015-N-0101-1401 | FDA | None FDA-2015-N-0101 | 050 Reference 39 - Evaluation of Chlorhexidine and Povidone Iodine Activity against Methicillin-Resistant Staphylococcus Aureus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:18:56Z | 0 | 0 | 0900006482cea5b2 | |||
| FDA-2015-N-0101-1405 | FDA | None FDA-2015-N-0101 | 054 Reference 43 - Furi et al, Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:21:58Z | 0 | 0 | 0900006482cea5b6 | |||
| FDA-2015-N-0101-1407 | FDA | None FDA-2015-N-0101 | 058 Reference 47 - Shamsudin et al, High Prevalence of QacaB Carriage among Clinical Isolates of Meticillin-Resistant Staphylococcus re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:23:52Z | 0 | 0 | 0900006482cea5b9 | |||
| FDA-2015-N-0101-1413 | FDA | None FDA-2015-N-0101 | 064 Reference 53 - Khor, In use Testing of disinfectants in Malaysian government hospitals re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:28:35Z | 0 | 0 | 0900006482cea7ca | |||
| FDA-2015-N-0101-1363 | FDA | None FDA-2015-N-0101 | 012 Reference 2 -11 - Volume_IX_9_of_9_References_Continuation_re_C12 re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:47:47Z | 0 | 0 | 0900006482cea4bf | |||
| FDA-2015-N-0101-1379 | FDA | None FDA-2015-N-0101 | 028 Reference 17 - Rotter et al Population Kinetics of the Skin Flora on Gloved Hands Following Surgical Hand Disinfection 2007 re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:03:07Z | 0 | 0 | 0900006482cea912 | |||
| FDA-2015-N-0101-1380 | FDA | None FDA-2015-N-0101 | 029 Reference 18 - Beldame et al, Surgical glove bacterial contamination and perforation during total hip arthroplasty implantation- When gloves should be changed re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:03:52Z | 0 | 0 | 0900006482cea913 | |||
| FDA-2015-N-0101-1361 | FDA | None FDA-2015-N-0101 | 009 Reference 2 -8 - Volume_VI_6_of_9_References_Continuation_re_C12 re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:46:05Z | 0 | 0 | 0900006482cea4bc | |||
| FDA-2015-N-0101-1385 | FDA | None FDA-2015-N-0101 | 034 Reference 23 - FDA, Draft Guidance for Industry on Endocrine Disruptin Potention of Drugs re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:07:37Z | 0 | 0 | 0900006482cea5a2 | |||
| FDA-2015-N-0101-1373 | FDA | None FDA-2015-N-0101 | 022 Reference 11 - FDA_Letter_regarding_Deferral_of_Benzethonium_Chloride re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:57:24Z | 0 | 0 | 0900006482cea90c | |||
| FDA-2015-N-0101-1429 | FDA | None FDA-2015-N-0101 | 080 Reference 69 - Stickler et al, Antiseptic and antibiotic resistance in gram-negative bacteria causing urinary tract infection in spinal cord injured patients re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:41:57Z | 0 | 0 | 0900006482ceabe9 | |||
| FDA-2015-N-0101-1435 | FDA | None FDA-2015-N-0101 | 086 Reference 75 - Braoudaki et al, Adaptive Resistance to Biocides in Salmonella Enterica and Escherichia Coli O157 and Cross-Resistance re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:43:04Z | 0 | 0 | 0900006482ceabef | |||
| FDA-2015-N-0101-1396 | FDA | None FDA-2015-N-0101 | 045 Reference 34 - Comparative Susceptibility of Resident and Transient Hand Bacteria to Para-Chloro-Meta-Xylenol and Triclosan re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:15:24Z | 0 | 0 | 0900006482cea5ad | |||
| FDA-2015-N-0101-1356 | FDA | None FDA-2015-N-0101 | 004 Reference 2 -3 - Volume_III_3_of_9_Reference_List_re_Comment_from_Soap_Detergent_Association_(SDA) re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:41:36Z | 0 | 0 | 0900006482ce9f71 | |||
| FDA-2015-N-0101-1354 | FDA | None FDA-2015-N-0101 | 002 Reference 2 -1 - Volume_I_1_of_9_Soap_and_Detergent_Association_SDA_Comment_re_Comment_from_Soap_Detergent_Association_(SDA) re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:39:26Z | 0 | 0 | 0900006482ce9f6f | |||
| FDA-2015-N-0101-1357 | FDA | None FDA-2015-N-0101 | 005 Reference 2 -4 - Volume_IV_4_of_9_References_Continuation_re_Comment_from_Soap_Detergent_Association_(SDA) re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T14:42:14Z | 0 | 0 | 0900006482ce9f72 | |||
| FDA-2015-N-0101-1383 | FDA | None FDA-2015-N-0101 | 032 Reference 21 - Briefing Document for a NDAC meeting September 2014 re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:06:21Z | 0 | 0 | 0900006482cea917 | |||
| FDA-2015-N-0101-1418 | FDA | None FDA-2015-N-0101 | 069 Reference 58 - Giacometti et al, Antiseptic Compounds Still Active against Bacterial Strains Isolated from Surgical Wound Infections re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:32:20Z | 0 | 0 | 0900006482ceabde | |||
| FDA-2015-N-0101-1419 | FDA | None FDA-2015-N-0101 | 070 Reference 59 - Gocke et al 1985 In vitro Studies of the Killing of Clinical Ioslates by Povidone-Iodine Solutions re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:33:00Z | 0 | 0 | 0900006482ceabdf | |||
| FDA-2015-N-0101-1393 | FDA | None FDA-2015-N-0101 | 042 Reference 31 - Geraldo et al Rapid Antibacterial Activity of 2 Noval Hand Soaps 2008 re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2017-12-20T05:00:00Z | 2017 | 12 | 2017-12-20T15:13:12Z | 0 | 0 | 0900006482cea5aa | |||
| FDA-2015-N-0101-1349 | FDA | None FDA-2015-N-0101 | Report from American Cleaning Institute | Other | Report | 2017-12-19T05:00:00Z | 2017 | 12 | 2017-12-19T05:00:00Z | 2017-12-19T20:38:13Z | 0 | 0 | 0900006482d142ac | ||
| FDA-2015-N-0101-1348 | FDA | None FDA-2015-N-0101 | Letter from American Cleaning Institute | Other | Letter(s) | 2017-11-24T05:00:00Z | 2017 | 11 | 2017-11-24T05:00:00Z | 2017-11-24T15:29:46Z | 0 | 0 | 0900006482c51176 | ||
| FDA-2015-N-0101-1347 | FDA | None FDA-2015-N-0101 | Supplement from American Chemistry Council | Other | Supplement (SUP) | 2017-10-18T04:00:00Z | 2017 | 10 | 2017-10-18T04:00:00Z | 2017-10-18T19:39:02Z | 0 | 0 | 0900006482ba06d0 | ||
| FDA-2015-N-0101-1346 | FDA | None FDA-2015-N-0101 | Letter to Medtronic re Isopropyl Alcohol Deferral | Other | Letter(s) | 2017-10-03T04:00:00Z | 2017 | 10 | 2017-10-03T04:00:00Z | 2017-10-03T16:25:17Z | 0 | 0 | 0900006482b9515a | ||
| FDA-2015-N-0101-1344 | FDA | None FDA-2015-N-0101 | Supplement from American Chemistry Council | Other | Supplement (SUP) | 2017-09-27T04:00:00Z | 2017 | 9 | 2017-09-27T04:00:00Z | 2017-09-27T20:22:49Z | 0 | 0 | 0900006482b777ee | ||
| FDA-2015-N-0101-1345 | FDA | None FDA-2015-N-0101 | Supplement from American Chemistry Council | Other | Supplement (SUP) | 2017-09-27T04:00:00Z | 2017 | 9 | 2017-09-27T04:00:00Z | 2017-09-27T20:24:34Z | 0 | 0 | 0900006482b77df3 | ||
| FDA-2015-N-0101-1343 | FDA | None FDA-2015-N-0101 | Letter from FDA to American Cleaning Institute | Other | Letter(s) | 2017-09-11T04:00:00Z | 2017 | 9 | 2017-09-11T04:00:00Z | 2017-09-11T12:07:41Z | 0 | 0 | 0900006482b1a92e | ||
| FDA-2015-N-0101-1338 | FDA | None FDA-2015-N-0101 | Letter from Medtronic | Other | Letter(s) | 2017-05-08T04:00:00Z | 2017 | 5 | 2017-05-08T04:00:00Z | 2017-05-08T15:49:53Z | 0 | 0 | 0900006482577b21 | ||
| FDA-2015-N-0101-1337 | FDA | None FDA-2015-N-0101 | Letter from American Chemistry Council | Other | Letter(s) | 2017-05-08T04:00:00Z | 2017 | 5 | 2015-05-01T04:00:00Z | 2015-10-29T03:59:59Z | 2017-05-08T15:46:40Z | 0 | 0 | 090000648255f81f | |
| FDA-2015-N-0101-1327 | FDA | None FDA-2015-N-0101 | Report from The American Cleaning Institute (ACI) | Other | Report | 2017-02-14T05:00:00Z | 2017 | 2 | 2017-02-14T05:00:00Z | 2017-03-22T17:18:48Z | 0 | 0 | 09000064824c0c81 | ||
| FDA-2015-N-0101-1321 | FDA | None FDA-2015-N-0101 | FDA Letter regarding Deferral of Benzalkonium Chloride | Other | Letter(s) | 2017-01-19T05:00:00Z | 2017 | 1 | 2017-01-19T05:00:00Z | 2017-01-19T15:14:59Z | 0 | 0 | 09000064824849ae |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;